These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36181125)
1. Construction of a 3-mRNA hypoxia prognostic model to evaluate immune microenvironment in hepatocellular carcinoma. Wang J; Jin Z; Wu G; Deng Z; Wang J; Xu B; Zhu H; Guo Y; Wen Z Medicine (Baltimore); 2022 Sep; 101(39):e30589. PubMed ID: 36181125 [TBL] [Abstract][Full Text] [Related]
2. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. Zhang B; Tang B; Gao J; Li J; Kong L; Qin L J Transl Med; 2020 Sep; 18(1):342. PubMed ID: 32887635 [TBL] [Abstract][Full Text] [Related]
3. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma. Mo Z; Liu D; Rong D; Zhang S Front Immunol; 2021; 12():611058. PubMed ID: 33679749 [No Abstract] [Full Text] [Related]
4. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
6. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z Front Immunol; 2021; 12():653836. PubMed ID: 33897701 [No Abstract] [Full Text] [Related]
7. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654 [TBL] [Abstract][Full Text] [Related]
8. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma. Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375 [TBL] [Abstract][Full Text] [Related]
9. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response. Chen J; Chen X; Li T; Wang L; Lin G Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273 [TBL] [Abstract][Full Text] [Related]
10. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
11. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma. Zhang G; Zhang K; Zhao Y; Yang Q; Lv X BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma. Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of an immune-related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma. Yang CB; Feng HX; Dai CL Cancer Med; 2022 Jun; 11(11):2329-2341. PubMed ID: 35092175 [TBL] [Abstract][Full Text] [Related]
15. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma. Chen W; Yang Z; Chen Y Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252 [TBL] [Abstract][Full Text] [Related]
16. A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma. Shi Y; Wang J; Huang G; Zhu J; Jian H; Xia G; Wei Q; Li Y; Yu H Hepatol Int; 2022 Aug; 16(4):906-917. PubMed ID: 35699863 [TBL] [Abstract][Full Text] [Related]
17. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma. Liu T; Wu H; Qi J; Qin C; Zhu Q Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653 [TBL] [Abstract][Full Text] [Related]
18. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation. Guan R; Zou J; Mei J; Deng M; Guo R BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846 [TBL] [Abstract][Full Text] [Related]
19. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma. Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]